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• Communicate national 
PE/E policy and guide-
lines to all stakeholders, 
program managers, and 
service providers. 
• Distribute national poli-
cies throughout the health 
system, including primary 
facilities. 
• National policies include 
prevention and manage-
ment of PE/E protocols 
at secondary and tertiary 
facilities. 
• Train providers at primary 
and secondary facilities 
on prevention and man-
agement of PE/E. 
• Collaborate with phar-
maceutical companies to 
manufacture and package 
single IM loading dose of 
MgSO4.
• Introduce task sharing 
policy for the administra-
tion of aspirin and antihy-
pertensive drugs by prima-
ry facility providers. 
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POLICIES FOR PRE-ECLAMPSIA AND ECLAMPSIA       
PREVENTION AND MANAGEMENT
Each day, more than 830 women and 7,200 babies die from pregnancy- or child-
birth-related causes. These complications also lead to 7,000 stillbirths daily. 
Ninety nine percent of these deaths occur in developing countries. Despite glob-
al efforts to reduce preventable maternal and newborn mortality, Bangladesh 
still experiences between 5,000 and 6,000 maternal deaths each year. Of those 
deaths, 20 percent are from pre-eclampsia and eclampsia (PE/E), the second 
most common direct cause of maternal mortality in the country. These deaths are 
preventable.                                                                                                                                              
In Bangladesh, best practices to prevent PE/E using aspirin and calcium and 
manage through task sharing and using magnesium sulphate (MgSO4) and anti-
hypertensive drugs have not been optimally examined. 
RESEARCH 
To appreciate the enormity of the problem, the Population Council conducted a 
landscape analysis in 12 upazilas in four districts. The study was cross sectional, 
and data collection activities included in-depth interviews (IDIs) with policy mak-
ers, development partners, program managers, and Ob/Gyn professionals and 
primary facility providers. The study’s objective was to identify existing national 
policies and guidelines for PE/E management and prevention, as well as to doc-

















Central Medical Store of Drugs (CMSD) to District Reser-
vation Stores (DRS). If these medicines are supplied to 
DRS, they are either stored there or sent to the district 
hospitals (DH) or upazila health complexes (UHC), de-
pending upon the need. 
The DGHS allocates 20 percent of its budget to the CMSD 
to locally procure medicines, including antihypertensive 
drugs, usually purchased quarterly through CMSD or by 
local purchase through a competitive bidding process. In 
exploring the reasons for irregular supply of these drugs, 
where the incidence of PE/E is lower, facilities appear to 
not use the drugs frequently and many drugs in expire on 
the shelves. 
Prevention measures 
Aspirin is not seen as a preventive drug for PE/E and 
there is no policy. Calicum is regularly supplied to preg-
nant women during ANC, although many providers are 
unaware of its use in preventing pre-eclampsia. 
Improving the referral system 
Interviewees were evenly divided about functionality of 
the current referral system. Half of the respondents be-
lieve it functions well, while others disagree.  All belive it 
needs to be strengthened, however.  
“In the health system, the entry and exit points for 
a patient are not fixed. For the common cold, pa-
tients are going to Dhaka Medical College Hospital, 
as well as to Community Clinics. Then how does the 
referral system work? Sending the patient with only 
a referral slip is not a true referral. It is not followed 
appropriately. We need to discuss the issue of the 
referral system at national level.” 
   Deputy Director, DGFP
Reducing deaths from PE/E in Bangladesh is possible. 
Essential drugs and equipment must be available in facil-
ities, and providers at all tiers of the health system must 
know detection, prevention, and treatment measures 
and be able to refer women for management.  
FINDINGS
Government policies  
National policies for maternal health and standard op-
erating procedures encompass prevention and manage-
ment of complications like PE/E, but there is no specific 
policy that outlines detection, prevention, and treatment. 
A developed, tested, and approved protocol for primary 
health care (PHC) providers, ready for implementation in 
the field, has not yet been circulated, and program man-
agers and service providers are unaware it exists. 
“I don’t know about the government policy. There 
might be one, but I cannot tell you about it, as I 
didn’t get the policy in my hand. I don’t know about 
where the policy is being implemented. There is no 
implementation policy in my district or upazilas.” 
         Policy Maker and Program Manager, MoHFW 
Task sharing
Interviewees were aware of evidence about task sharing 
for detecting and managing PE/E using the loading dose 
of MgSO4 and referring women to secondary and tertiary 
facilities. Almost all policy level respondents believe that 
task sharing to lower cadre providers can have a positive 
impact on maternal health outcomes. They stressed the 
need for proper training and mentoring of lower level pro-
viders, however.
“We say that we made progress toward the MDG 
goals, but still most of the deliveries are taking 
place at home. If there is any problem, they first 
come to the grass roots health workers. If we can 
make the service providers more aware and train 
them at the community level, then they can identify 
PE/E, administer the loading dose of MgSO4, and 
refer. Then it will definitely have a good effect and 
will reduce maternal mortality.” 
UNFPA Participant 
Essential drugs for PE/E 
Magnesium sulphate, calcium gluconate and antihyper-
tensive drugs are essential for providing comprehensive 
treatment of PE/E. The Directorate General of Family 
Planning (DGFP) does not suppy these drugs to its facili-
ties, rather, they expect pregnant women presenting with 
PE/E to be referred to a higher level facility with the ap-
propriate medicines. In the Directorate General of Health 
Services (DGHS), MgSO4 and calcium gluconate (the an-
tidote to MgSO4 toxicity) are supplied irregularly by the 
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